NEW COMBINATION OF FORMOTEROL AND BUDESONIDE

NEW COMBINATION OF FORMOTEROL AND BUDESONIDE

Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesoni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CARLING, CHRISTER CARL GUSTAV, TROFAST, JAN WILLIAM
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CARLING, CHRISTER CARL GUSTAV
TROFAST, JAN WILLIAM
description Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesonide is pref. 1:4-1:70, used combined or separately. Suitable daily doses are 6-100(esp. 6-48) mg formoterol and 50-4800 (esp. 100-1600) micro-g budesonide divided into two doses a day.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HK1010339A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HK1010339A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HK1010339A13</originalsourceid><addsrcrecordid>eNrjZNDxcw1XcPb3dfL0cwzx9PdT8HdTcPMP8vUPcQ3y91Fw9HNRcAp1cQ329_N0ceVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEe3oYGhgbGxpaOhsZEKAEAS00kqQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW COMBINATION OF FORMOTEROL AND BUDESONIDE</title><source>esp@cenet</source><creator>CARLING, CHRISTER CARL GUSTAV ; TROFAST, JAN WILLIAM</creator><creatorcontrib>CARLING, CHRISTER CARL GUSTAV ; TROFAST, JAN WILLIAM</creatorcontrib><description>Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesonide is pref. 1:4-1:70, used combined or separately. Suitable daily doses are 6-100(esp. 6-48) mg formoterol and 50-4800 (esp. 100-1600) micro-g budesonide divided into two doses a day.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990617&amp;DB=EPODOC&amp;CC=HK&amp;NR=1010339A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19990617&amp;DB=EPODOC&amp;CC=HK&amp;NR=1010339A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CARLING, CHRISTER CARL GUSTAV</creatorcontrib><creatorcontrib>TROFAST, JAN WILLIAM</creatorcontrib><title>NEW COMBINATION OF FORMOTEROL AND BUDESONIDE</title><description>Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesonide is pref. 1:4-1:70, used combined or separately. Suitable daily doses are 6-100(esp. 6-48) mg formoterol and 50-4800 (esp. 100-1600) micro-g budesonide divided into two doses a day.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDxcw1XcPb3dfL0cwzx9PdT8HdTcPMP8vUPcQ3y91Fw9HNRcAp1cQ329_N0ceVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEe3oYGhgbGxpaOhsZEKAEAS00kqQ</recordid><startdate>19990617</startdate><enddate>19990617</enddate><creator>CARLING, CHRISTER CARL GUSTAV</creator><creator>TROFAST, JAN WILLIAM</creator><scope>EVB</scope></search><sort><creationdate>19990617</creationdate><title>NEW COMBINATION OF FORMOTEROL AND BUDESONIDE</title><author>CARLING, CHRISTER CARL GUSTAV ; TROFAST, JAN WILLIAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HK1010339A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CARLING, CHRISTER CARL GUSTAV</creatorcontrib><creatorcontrib>TROFAST, JAN WILLIAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CARLING, CHRISTER CARL GUSTAV</au><au>TROFAST, JAN WILLIAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW COMBINATION OF FORMOTEROL AND BUDESONIDE</title><date>1999-06-17</date><risdate>1999</risdate><abstract>Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesonide is pref. 1:4-1:70, used combined or separately. Suitable daily doses are 6-100(esp. 6-48) mg formoterol and 50-4800 (esp. 100-1600) micro-g budesonide divided into two doses a day.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_HK1010339A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title NEW COMBINATION OF FORMOTEROL AND BUDESONIDE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A56%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CARLING,%20CHRISTER%20CARL%20GUSTAV&rft.date=1999-06-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHK1010339A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true